Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 5/20 | 0.30 |
| ▸ | CNR1 | P21554 | 4/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23636580 | 0.94 | VCAM1 (0.33) | VCAM1ALOX15 | |
| SCHEMBL23636598 | 0.86 | MAPK14 (0.34) | MAPK14 | |
| SCHEMBL23636556 | 0.84 | MEN1 (0.37) | VCAM1MAPK14 | |
| SCHEMBL23636557 | 0.82 | MAPK14 (0.37) | CYP3A4CYP2C9CYP2C19VCAM1MAPK14 | |
| SCHEMBL23636572 | 0.82 | VCAM1 (0.33) | VCAM1 | |
| SCHEMBL23636568 | 0.81 | PTGS2 (0.33) | VCAM1 | |
| SCHEMBL23636583 | 0.80 | PTGS2 (0.35) | — | |
| SCHEMBL21586951 | 0.79 | PDE2A (0.35) | CNR1 | |
| SCHEMBL24914000 | 0.78 | VCAM1 (0.30) | VCAM1 | |
| SCHEMBL21586950 | 0.77 | NR1I2 (0.33) | MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210214321-A1 | NOVEL REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF | EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION (TW) | 2021-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210214321-A1 | NOVEL REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF | SULT1A1, XDH, SULT2A1 | CYP3A4 86/4885CYP2C9 266/4885CYP2C19 270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.